KHALAFALLAH, Alhossain A.; FERNANDOPULLE, Bernadene; BRAIN, Terry. Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 2, n. 2, p. e2010012, 2010. DOI: 10.4084/mjhid.2010.012. Disponível em: https://www.mjhid.org/mjhid/article/view/2010.012. Acesso em: 16 apr. 2024.